ERA BIOLOGY Great Show at Africa Health 2022
Gallagher Convention Center, Johannesburg, South Africa – 26th-28th October – ERA BIOLOGY participated in Africa Health 2022, which is the most influent...
From January 2020 to October 2020, a prospective methodological study was conducted at the Pisa University Hospital which published on BMC Microbiology. Goldstream® Fungus (1-3)-β-D-Glucan Test was...
Era Biology will host global live webinar at 19th May 2022 16:00 (UTC/GMT +08:00). The webinar will focus on early and rapid diagnostic solution for invasive fungal disease. The latest technology f...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
Tianjin, China – August 9, 2022 – Tianjin Era Biology Technology Co., Ltd was award as National Professionalization, Refinement, Characteristic and Novelty “Little Giant” by National Ministry of In...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...